Skip to content
Clinical Trials – home
PolandBack to Poland

Clinical trials in Torun – page 76

918 clinical trials in Torun, Poland across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

PolandOur site in PolandBadaniaKliniczne.pl(opens in a new tab)
Torun at a glance
918
clinical trials
  • Research sites2
Type of trial
Recruitment status
Quick filters

918 trials in Torun

Open in trial search

Neoplasm malignant+2

Not recruiting

Study on the Safety and Effects of LY2880070 and Gemcitabine in Patients with Advanced or Metastatic Cancer, Focusing on Ovarian Cancer

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Gemcitabine
  • Sponsor:Esperas Pharma Inc.

Alopecia areata

Not recruiting

Study on Baricitinib for Treating Children Aged 6 to 17 with Alopecia Areata

Registered drug
Countries:PolandPoland
  • Participants:0–17 years
  • Substances:Baricitinib
  • Sponsor:Eli Lilly & Co.

Diabetic retinopathy

Not recruiting

Study on BI 764524 for Patients with Moderate to Severe Diabetic Retinopathy

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:BI 764524
  • Sponsor:Boehringer Ingelheim International GmbH

Study on Cabozantinib, Nivolumab, and Ipilimumab for Patients with Advanced or Metastatic Kidney Cancer Who Have Not Received Prior Treatment

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Cabozantinib
  • Sponsor:Exelixis Inc.

Diabetic neuropathy+1

Not recruiting

Study on the Effectiveness of ODM-111 and Paracetamol for Chronic Pain in Patients with Diabetic Peripheral Neuropathy

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:ODM-111
  • Sponsor:Orion Corporation

Dermatitis atopic

Not recruiting

Study on the Safety and Effectiveness of Upadacitinib and Dupilumab for Children Aged 2 to 12 with Moderate to Severe Atopic Dermatitis

Registered drugNo placebo
Countries:PolandPoland
  • Participants:0–17 years
  • Substances:Dupilumab
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Study on the Effectiveness and Safety of Cenerimod for Adults with Moderate to Severe Systemic Lupus Erythematosus

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Cenerimod
  • Sponsor:Viatris Innovation GmbH

Study on Imatinib and Chemotherapy Combination for Children with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Registered drugNo placebo
Countries:PolandPoland
  • Participants:0–17 years · 18–64 years
  • Substances:Crisantaspase
  • Sponsor:Universita Degli Studi Di Milano Bicocca

Study on the Safety and Tolerability of VRDN-001 for Patients with Thyroid Eye Disease

InvestigationalNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:VRDN-001
  • Sponsor:Viridian Therapeutics Inc.

Study on Acute Lymphoblastic Leukemia Treatment in Children and Adolescents Using Bortezomib, Blinatumomab, and Methotrexate Combination

Registered drugNo placebo
Countries:PolandPoland
  • Participants:0–17 years
  • Substances:Blinatumomab
  • Sponsor:Medical University Of Silesia Katowice Poland

Major depression

Not recruiting

Study on Aticaprant for Adults with Major Depressive Disorder and Anhedonia Not Responding to Antidepressants

Investigational
Countries:PolandPoland
  • Participants:18–64 years
  • Substances:Aticaprant
  • Sponsor:Janssen Cilag International

Cardiac failure+4

Not recruiting

Study on the Effects of CDR132L in Patients with Reduced Heart Function After a Heart Attack

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:CDR132L
  • Sponsor:Cardior Pharmaceuticals GmbH

Other cities in Poland

The busiest research cities in the country

All 236 cities in Poland

Clinical research in Torun

What the registry says about research in the country

01 Infectious Disease Prevention

Clinical research focusing on vaccine development for various infectious diseases, including studies on chickenpox, meningococcal, and pneumococcal vaccines. Trials evaluate immune responses in children and toddlers.

  • Varicella vaccine studies
  • Meningococcal ACYW research
  • Pneumococcal conjugate vaccines

These studies aim to enhance protection against common childhood infections through innovative immunization strategies.

02 Autoimmune Conditions

Extensive research into treatments for inflammatory disorders, with particular focus on novel therapies for conditions affecting joints and skin.

  • Psoriatic Arthritis treatments
  • Ulcerative Colitis therapies
  • Atopic Dermatitis solutions

Clinical trials are evaluating new biological and small molecule treatments to improve patient outcomes.

03 Oncology and Hematology

Advanced research in blood cancers and related conditions, focusing on innovative therapeutic approaches.

  • Acute Myeloid Leukemia treatments
  • Chronic Lymphocytic Leukemia therapies
  • Prostate Cancer interventions

Studies evaluate combination therapies and novel compounds for improved treatment outcomes.

04 Chronic Disease Management

Research targeting long-term conditions affecting quality of life, including cardiovascular and joint disorders.

  • Heart Failure prevention
  • Osteoarthritis treatments
  • IgA Nephropathy studies

Trials focus on developing therapeutic solutions for chronic condition management.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.